The assay was first validated using samples where cells were treated with RNAi against Fat1 (figure S6) and after further optimization, the specificity of the ELISA was determined using the two pancreatic cancer serum samples displayed in figure S5. The gene discussed is FAT1; the disease is pancreatic neoplasm.